Manufacturing Chemist Manufacturing Chemist
  • Home
  • Ingredients
  • Analysis
  • Manufacturing
  • Finance
  • Events
  • Directory
  • Regulatory
  • Drug Delivery
  • Research & Development
  • Sustainability

Celgene

www.celgene.com

86 Morris Avenue
Summit
New Jersey
NJ 07901
United States

+1 908 673 9000

Activities

Research & Development | Pharmaceutical

Related Companies

  • Icrom SRL
  • Nanoform
  • Starlab
  • PCI Pharma Services
  • Solvias
  • Piramal Pharma Solutions
  • Butterworth Laboratories
  • Hermes Pharma GmbH
  • Ecolab Life Sciences
  • Vectorbuilder Inc
  • Indena
  • Quotient Sciences
  • ProtaGene
  • Actylis – The Partner of Choice

Related Content

ISPE names Facility of the Year 2019
ISPE names Facility of the Year 2019
BMS' acquisition of Celgene could position the company amongst top five most profitable pharma giants
BMS' acquisition of Celgene could position the company amongst top five most profitable pharma giants
Bristol-Myers Squibb to merge with Celgene in multimillion deal
Bristol-Myers Squibb to merge with Celgene in multimillion deal
GlobalData publishes analysis of top 25 global pharma companies
GlobalData publishes analysis of top 25 global pharma companies
Vanderbilt University Medical Center launches Nashville Biosciences
Vanderbilt University Medical Center launches Nashville Biosciences
GlobalData names top 25 global pharma companies by market cap
GlobalData names top 25 global pharma companies by market cap
Celgene set to become leader in CAR-T space
Celgene set to become leader in CAR-T space
Cancer Research UK announces collaboration with Celgene
Cancer Research UK announces collaboration with Celgene
CHMP give go ahead to expand REVLIMID as maintenance therapy for multiple myeloma
CHMP give go ahead to expand REVLIMID as maintenance therapy for multiple myeloma
AstraZeneca enhances long-term oncology growth strategy with Acerta investment
AstraZeneca enhances long-term oncology growth strategy with Acerta investment
Per patient costs for orphan drugs are 13.8 times higher than non-orphan drugs
Per patient costs for orphan drugs are 13.8 times higher than non-orphan drugs
City confirms plans for former Merck site to be Celgene campus
City confirms plans for former Merck site to be Celgene campus
Homing in on cancer targets
Homing in on cancer targets
New NCEs focus on cancer and orphan diseases
New NCEs focus on cancer and orphan diseases
NCEs target cancer
NCEs target cancer
  • Advertise Subscribe
  • Terms & Conditions
  • Privacy Policy
  • Contact us at info@hpcimedia.com
Twitter LinkedIn RSS newsfeed
© HPCi Media Limited | Registered in England No. 6716035 | VAT GB 939828072 | a Claverley Group company